Page last updated: 2024-08-23

amikacin and Neutropenia

amikacin has been researched along with Neutropenia in 166 studies

Research

Studies (166)

TimeframeStudies, this research(%)All Research%
pre-199046 (27.71)18.7374
1990's57 (34.34)18.2507
2000's49 (29.52)29.6817
2010's13 (7.83)24.3611
2020's1 (0.60)2.80

Authors

AuthorsStudies
Ahmad, MN; Chopra, S; Dasgupta, A; Garg, T; Kaur, P; Krishnamurthy, RV; Malik, P; Shukla, R; Singh, S1
Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK1
Chopra, S; Das, S; Dasgupta, A; Karaulia, P; Pandey, AK; Pandey, M; Singh, AK; Soni, I; Thakare, R1
Böttger, EC; Freihofer, P; Lenaerts, A; Meyer, M; Scherman, M; Teague, J1
Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF1
Giannakakis, T; Hatzitolios, A; Kollaras, P; Kordosis, T; Metallidis, S; Nikolaidis, J; Nikolaidis, P; Seitanidis, B1
Carlesse, FA; da Silva, KV; de Martino Lee, ML; Luisi, FA; Pereira, CA; Petrilli, AS1
Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK1
Agarwala, S; Bakhshi, S; Gupta, A; Pandey, RM; Swaroop, C1
Berneman, ZN; Goossens, H; Mebis, J1
Bastús, R; Cirera, L; Estany, C; Estrada, C; Garau, J; Gómez, I; Gómez, L; Márquez, M; Martí, JM; Quintana, S1
Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N1
Kılıç, SC; Sarper, N; Zengin, E1
Landau, Z; Miller, EB; Shichmanter, R; Shtalrid, M1
Bompolaki, I; Bozionelou, V; Falagas, ME; Kalpadaki, C; Karageorgopoulos, DE; Koutsounaki, E; Mitsikostas, P; Samonis, G; Sgouros, J; Taktikou, V1
Alfandari, S; Allorge, D; Berthon, C; Blondiaux, N; Cliquennois, E; Gay, J; Herbaux, C; Mareville, J; Pasquier, F1
Chaffanel-Peláez, M; Del Boz, J; Serrano-Martín, MM; Vera-Casaño, A1
Celebi, S; Demirkaya, M; Hacımustafaoglu, M; Sevinir, B1
Ben-Shimol, S; Fruchtman, Y; Greenberg, D; Hazan, G; Kapelushnik, J; Leibson, T1
Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A1
Barr-Alí, M; Burgaleta, C; De Miguel, D; García-Suárez, J; Hernanz, N; Krsnik, I; Reyes, E1
Casimir, L; Debbag, R; Fraquelli, L; Gómez, S; Iturres, AS; Latella, A; Paganini, H; Ruvinsky, S; Zubizarreta, P1
Blot, N; Marie-Cardine, A; Schneider, P; Tron, P; Vannier, JP1
Casini, C; Fanci, R; Leoni, F; Longo, G; Paci, C1
Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE1
Cypriano, M; Dantas, LS; Lee, LM; Petrilli, AS; Pires Pereira, CA; Torres B Silva, KV; Vercillo Luisi, MF1
Abdulkadyrov, KM; Chebotkevich, VN; Chudanova, TV1
Chiu, HH; Hung, KC; Lin, HC; Peng, CT; Tsai, FJ; Tseng, YC; Wang, JH1
Aksoylar, S; Cetingül, N; Kansoy, S; Kantar, M; Karapinar, D; Kavakli, K1
Akiyama, N; Imajo, K; Masaoka, T; Ohyashiki, K; Suzuki, K; Tamura, K; Tanimoto, M; Urabe, A1
Ohyashiki, K1
Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N1
Giltri, G; Isella, M; Larocca, A; Marinoni, S; Miccolis, I; Parma, M; Pogliani, EM; Rossini, F; Terruzzi, E; Verga, L1
Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C1
Takata, T; Tamura, K1
Aydogdu, I; Ersoy, Y; Kaya, E; Kuku, I; Serefhanoglu, K; Serefhanoglu, S1
Alexaki, P; Christakis, GB; Megalakaki, A; Perlorentzou, S; Zarkadis, IK1
Amador, ML; Arcediano, A; Bazares, S; Castellano, D; Ciruelos, E; Cortés-Funes, H; González-Cortijo, L; Hornedo, J; Jimeno, A; Lumbreras, C; Paz-Ares, L; Robles, L1
Ahmed, IA; Ahmed, N; El-Beshlawy, A; El-Haddad, A; El-Mahallawy, HA; Nassif, S1
Rosoff, PM; Saini, S1
Hamidah, A; Jamal, R; Lim, YS; Nordiah, AJ; Zarina, AL; Zulkifli, SZ1
Laoprasopwattana, K; Laosombat, V; Pruekprasert, P; Wongchanchailert, M1
Hamidah, A; Jamal, R; Nordiah, AJ; Rizal, AM1
Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I1
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR4
Carpenter, JL; Troxell, M; Wallace, RJ1
Klastersky, J; Lagast, H; Meunier, F; Piccart, M; Van Laethem, Y; Weerts, D1
Lönnqvist, B; Palmblad, J1
Dupont, J; Fernández, A; Garay, G; López, H; Marcenac, F; Pavlovsky, S; Scaglione, C1
Cafarelli, A; Cruciani, M; Magliulo, E; Piantieri, G1
Hindler, J; Martin, WJ; Meyer-Dudnik, PV; Young, LS1
Klastersky, J2
Deshpande, GN; Ettinger, LJ; Faden, HS; Freeman, AI; Grossi, M; Surgalla, M1
Costa, MA; Martins, CA; Nucci, M; Velasco, E1
Bucaneve, G; Buelli, M; Carotenuto, M; D'Antonio, D; Gentile, G; Liso, V; Martino, P; Menichetti, F; Nosari, AM; Ricci, P1
Allin, R; Folb, PI; Zent, CS1
Cony-Makhoul, P; Fière, D; Guy, H; Herbrecht, R; Marie, JP; Milpied, N; Pico, JL; Plantier, I; Vekhoff, A1
Aswapokee, N; Chayakul, P; Chuncharunee, S; Leelasuphasri, S; Sathapatayavongs, B; Siritanaratkul, N; Suwangool, P1
Bolis, S; Bregani, R; Casaroli, I; Corneo, G; Lanzi, E; Mingozzi, S; Pioltelli, P; Pogliani, EM; Rossini, F; Viganó, F1
de Oliveira, HP; Nucci, M; Pulcheri, WA; Spector, N1
Eguchi, K; Kojima, A; Ohe, Y; Okamoto, H; Oshita, F; Saijo, N; Sasaki, Y; Shinkai, T; Soejima, Y; Tamura, T1
Andremont, A; Chiche, D; Guiguet, M; Hayat, M; Lagrange, P; Lapierre, V; Marie, JP; Pico, JL; Richet, H; Tancrede, C1
Danisovicová, A; Drgona, L; Fuchsberger, P; Korec, S; Krcméry, V; Spánik, S; Svec, J1
Cunha, BA; Domenico, P; Straus, DC; Woods, DE1
Gentile, G; Girmenia, C; Martino, P; Meloni, G; Micozzi, A; Nucci, M; Venditti, M1
Benne, CA; Bruin, M; de Hoog, GS; Fleer, A; Neeleman, C1
Acuña, G; Duhalde, M; Grebe, G; Labarca, J; Lira, P; Ocqueteau, M; Oliva, J; Pérez, C; Sirham, M1
Atkinson, SA; Barr, RD; Halton, JM; Wu, B1
Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C1
Biard, O; Casassus, P; Guillevin, L; Lortholary, O; Padoin, C; Petitjean, O; Rizzo, N; Tod, M1
Deweerdt, C; Maire, P; Pivot-Dumarest, C; Roux, D; Sorensen, P; Troncy, J1
Bjökholm, M; Engervall, P; Günther, G; Hast, R; Kalin, M; Ljungman, P; Lönnqvist, B; Ringertz, S; Stiernstedt, G1
Aulagner, G; Barbé, G; Bertrand, Y; Bréant, V; Dürr, F; Nakache, C; Vray, C1
Cordonnier, C; Delain, M; Delmer, A; Gardembas, M; Gres, JJ; Herbrecht, R; Ladeb, S; Moreau, P; Nalet, V; Pico, JL; Rollin, C1
Charnas, R; Lüthi, AR; Ruch, W1
Bayle, C; Bourhis, JH; Cartron, J; Gautier, E; Pico, JL; Tchernia, G1
Behre, G; Hiddemann, W; Link, H; Maschmeyer, G; Meyer, P; Paaz, U; Wilhelm, M1
Casassus, P; Guillevin, L; Lortholary, O; Petitjean, O; Semaoun, R; Seytre, D; Tod, M; Uzzan, B1
McClure, JT; Rosin, E1
Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A1
Böhme, C; Hess, U; Rey, K; Senn, HJ1
Berneman, ZN; Bruyneel, P; Goossens, H; Mebis, J; Meeus, I; Schroyens, W; Sion, JP; Van Droogenbroeck, J1
Belmont-Martinez, L; Bernaldez-Rios, R; Miranda-Novales, MG; Penagos-Paniagua, M; Solorzano-Santos, F; Villasis-Keever, MA1
Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A1
Colomer, R; Cortés-Funes, H; García-Carbonero, R; Gómez, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM1
Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P1
Alimena, G; Battistini, R; Breccia, M; Celesti, F; Cimino, G; Coppola, L; Girmenia, C; Latagliata, R; Mandelli, F; Morano, SG; Spadea, A; Tafuri, A; Tosti, S1
Başkan, S; Ozyilkan, O; Yalçintaş, U1
Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi-Ferrini, P; Saccardi, R; Vannucchi, AM1
Caballero, D; Calvo, MV; Dominguez-Gil, A; Fdez de Gatta, MM; Lanao, JM; Romano, S1
Alimena, G; Celesti, F; Cimino, G; Coppola, L; D'Elia, GM; Girmenia, C; Latagliata, R; Mandelli, F; Mecarocci, S; Morano, SG; Spadea, A; Tafuri, A; Tosti, S1
Akan, H; Akova, M; Biberoğlu, K; Hayran, M; Kansu, E; Kars, A; Korten, V; Unal, S1
Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D1
Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA1
Fabbri, A; Fanci, R; Leoni, F; Longo, G; Martinez, RL; Paci, C; Pecile, P1
Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I1
Arasu, A; Ariffin, H; Ariffin, WA; Chan, LL; Lin, HP; Mahfuzah, M1
Engervall, P; Persson, L; Sjöberg, L; Tidefelt, U; Vikerfors, T1
Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P1
Bessho, M; Endo, K; Fukuda, M; Hirasima, K; Ito, K; Kawai, N; Tominaga, K1
Boffa, ML; De Blasi, D; Mastrullo, L; Miraglia, E; Orlando, R; Zorzato, G1
Agaoglu, L; Agirbasli, H; Anak, S; Bilgen, H; Biner, B; Can, M; Devecioglu, O; Eryilmaz, E; Gedikoglu, G; Goksan, B; Karakas, Z; Unuvar, A; Yalman, N1
Bucaneve, G; D'Antonio, D; Del Favero, A; Furno, P; Gentile, G; Mandelli, F; Martino, B; Martino, P; Menichetti, F; Micozzi, A; Ricci, P; Russo, D1
Baka, M; Gombakis, N; Kafetzis, DA; Koliouskas, DE; Kosmidou, H; Malaka-Zafiriou, E; Maltezou, HC1
Akan, H; Akova, M; Cetinkaya, Y; Erman, M; Ferhanoğlu, B; Köksal, I; Korten, V; Unal, S; Uzun, O1
Landau, M; Nucci, M; Pulcheri, W; Silveira, F; Spector, N1
Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA1
Acevedo, A; Escudero, A; Fernández-Rañada, JM; Gil-Fernández, JJ; Martínez, E; Martínez-Chamorro, C1
Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L1
Anguita, A; Loscos, J; Serra, A; Vila, M; Vivancos, J1
Batlle, M; Benlloch, L; Capote, FJ; Gutiérrez, M; Jarque, I; Julià, A; Lahuerta, JJ; Larrea, L; López, J; Palau, J; Pérez, C; Ramos, F; Rovira, M; Sanz, MA; Vázquez, L1
Coiffier, B; Espinouse, D; Felman, P; Fiere, D; Reynaud, J; Vialard, L; Vu Van, H1
Hairston, J; Sidell, J; Winston, DJ; Young, LS1
Bodey, GP; Keating, MJ; Rodriguez, V; Valdivieso, M1
Gisselbrecht, C; Marty, M; Samson-Lepors, MJ1
Kowarski, A; Lietman, PS; Vogelstein, B1
Abbas, Z; Karim, M; Malik, IA1
Ajarim, DS; al Mohareb, F; al Momen, AK; Harakati, MS; Santhosh-Kumar, CR; Zeitany, RG1
Gentile, G; Girmenia, C; Mandelli, F; Martino, P; Micozzi, A; Raccah, R1
Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P1
Bosseray, A; Brion, JP; Hollard, D; Michallet, M; Micoud, M; Nicolini, F; Stahl, JP1
Cimino, G; Gentile, G; Girmenia, C; Martino, P; Micozzi, A; Raccah, R; Sgadari, C1
Kibbler, CC; McWhinney, PH; Prentice, HG; Warner, P1
Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT1
Hirose, T; Kumamoto, Y; Tanaka, N; Yokoo, A1
Anaissie, EJ; Berkey, P; Bodey, GP; Cabanillas, FF; Elting, L; Holmes, FA; Joshi, JH; Keating, MJ; Khardori, NM; Rolston, KV1
Anak, S; Devecioğlu, O; Gedikoğlu, G; Ovali, F; Zülfikar, B1
Avlami, A; Meletis, J; Rombos, Y; Vayopoulos, G; Yataganas, X1
Bauters, F; Blanc, C; Pollet, JP1
Davis, RL; Lehmann, D; Neidhart, J; Stidley, CA1
Amadori, S; Martino, P; Micozzi, A; Pulsoni, A; Tirindelli, C; Venditti, M1
Aversa, F; Bucaneve, G; Del Favero, A; Fiorio, M; Menichetti, F1
Bodey, GP; Elting, L; Fainstein, V; Rosenbaum, B1
Abumelha, A; al-Fadil, M; al-Mulhim, I; Sumer, T1
Baker, DK; Goren, MP; Shenep, JL1
Bodunkova, LE; Ivanitskaia, LP; Kudinova, MK; Samoĭlova, LN; Viadro, MM1
Arnow, P; Edlin, B; Flaherty, JP; George, D; O'Keefe, P; Waitley, D; Weinstein, RA1
Benn, R; Benson, W; Date, L; Gibson, J; Iland, H; Joshua, DE; Kronenberg, H; Vincent, PC; Wilson, A; Young, GA1
Benedetti, M; Gasparini, G; Talamini, R; Toffoli, G; Tumolo, S; Vaglia, A1
Angelini, A; Betti, S; D'Antonio, D; Dell'Isola, M; di Girolamo, A; Dragani, A; Fioritoni, G; Iacone, A; Piccolomini, R1
Agaliotis, D; Ezzeddine, H; Gala, JL; Gigi, J; Michaux, JL; Vandercam, B; Wauters, G1
Brice, P; Calvo, F; de Castro, H1
Brion, JP; Bru, JP; Corron, B; Fauconnier, J; Michallet, M1
Ajchenbaum, F; Baume, D; Chiche, D; Delmer, A; Fitoussi, F; Marie, JP; Pico, JL; Richet, H; Rio, B; Tancrède, C1
Baker, DK; Blankenship, KR; Feldman, S; Gigliotti, F; Hughes, WT; Meyer, WH; Roberson, PK; Santana, VM; Shenep, JL; Sixbey, JW1
Artino, RM; Dotti, G; Giacchino, M; Grazia, G; Madon, E; Mattirolo, F; Miniero, R; Vivalda, M1
Avvisati, G; Fenu, S; Girmena, C; Martino, P; Micozzi, A; Raccah, R; Santilli, S1
Nightingale, CH; Quintiliani, R; Shyu, WC1
Colucci, A; Coniglio, M; Girardi, F; Guarini, A; Iaculli, L; Liso, V; Pavone, V; Specchia, G1
Munro, R; Rawlinson, W; Sorrell, T1
Andrien, F; Anniko, M; Baudrihaye, M; Bow, E; Burman, LA; Louie, T; Norberg, B; Norrby, SR; Runde, V; Vandercam, B1
Croydon, E; Weerts, D1
Chadwick, EG; Shulman, ST; Yogev, R2
Johnson, DE; Thompson, B1
Blaser, J; Dudley, M; Zinner, SH1
Zinner, SH1
Calia, FM; Johnson, DE; Thompson, B1
Andremont, AO; Tancrède, CH1
Shulman, ST; Yogev, R1

Reviews

3 review(s) available for amikacin and Neutropenia

ArticleYear
Febrile neutropenia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1993, Volume: 1, Issue:5

    Topics: Amikacin; Amphotericin B; Bacteremia; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Mycoses; Neoplasms; Neutropenia; Vancomycin; Virus Diseases

1993
Acute necrotizing gastritis by Escherichia coli in a severely neutropenic patient.
    Haematologica, 2002, Volume: 87, Issue:1

    Topics: Acute Disease; Amikacin; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Escherichia coli Infections; Gastric Mucosa; Gastritis; Granulocyte Colony-Stimulating Factor; Immunosuppressive Agents; Meropenem; Methylprednisolone; Necrosis; Neutropenia; Omeprazole; Parenteral Nutrition, Total; T-Lymphocytes; Thienamycins

2002
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
    The Pediatric infectious disease journal, 1989, Volume: 8, Issue:5

    Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin

1989

Trials

90 trial(s) available for amikacin and Neutropenia

ArticleYear
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    European journal of internal medicine, 2008, Volume: 19, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Ceftriaxone; Ciprofloxacin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Fever; Greece; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome

2008
Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2009, Volume: 42, Issue:2

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Male; Neutropenia; Treatment Outcome; Young Adult

2009
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:9

    Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Neoplasms; Neutropenia; Ofloxacin; Treatment Outcome

2009
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Fever of Unknown Origin; Humans; Incidence; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poisoning; Prospective Studies; Treatment Outcome; Young Adult

2010
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Japanese journal of clinical oncology, 2010, Volume: 40, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult

2010
Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
    Pediatric hematology and oncology, 2011, Volume: 28, Issue:4

    Topics: Acute Disease; Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Leukemia; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Young Adult

2011
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
    Pediatric hematology and oncology, 2013, Volume: 30, Issue:2

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Sulbactam; Tazobactam

2013
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
    Medical oncology (Northwood, London, England), 2002, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin

2002
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Cancer, 2003, Apr-01, Volume: 97, Issue:7

    Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Argentina; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Humans; Infant; Leukemia; Male; Neutropenia; Risk

2003
Ticarcillin-clavulanic acid plus amikacin versus ceftazidime plus amikacin in the empirical treatment of fever in acute leukemia: a prospective randomized trial.
    Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:3

    Topics: Adult; Aged; Amikacin; Ceftazidime; Chi-Square Distribution; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Survival Rate; Ticarcillin; Treatment Outcome

2003
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Cancer, 2003, Sep-01, Volume: 98, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin

2003
Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2003, Volume: 7, Issue:2

    Topics: Adolescent; Amikacin; Bacterial Infections; Brazil; Ceftriaxone; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Epidemiologic Methods; Female; Fever; Humans; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Neutropenia; Ticarcillin; Treatment Outcome

2003
[Cefepime/amikacin in the empirical antibacterial therapy for patients with hemoblastosis of different forms].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftriaxone; Cephalosporins; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Leukocyte Count; Neutropenia; Neutrophils; Time Factors; Treatment Outcome

2003
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2003, Volume: 36, Issue:4

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Diarrhea; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Cocci; Hospitals, University; Humans; Infant; Male; Meropenem; Neoplasms; Neutropenia; Taiwan; Thienamycins; Treatment Outcome

2003
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Pediatric hematology and oncology, 2004, Volume: 21, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infections; Meropenem; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins

2004
Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-15, Volume: 39 Suppl 1

    Topics: Amikacin; Antineoplastic Agents; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Japan; Leukemia; Male; Neutropenia; Opportunistic Infections

2004
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:6

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome

2005
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Current medical research and opinion, 2005, Volume: 21, Issue:5

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome

2005
Clinical experience with three combination regimens for the treatment of high-risk febrile neutropenia.
    Annals of the Academy of Medicine, Singapore, 2006, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Immunocompromised Host; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Risk Assessment; Risk Factors; Tazobactam; Thienamycins

2006
Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:12

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Stem Cell Transplantation; Treatment Outcome

2006
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:6

    Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Sepsis; Time Factors

2007
Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Singapore medical journal, 2007, Volume: 48, Issue:7

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Remission Induction

2007
Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides.
    Pediatric hematology and oncology, 2007, Volume: 24, Issue:8

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Child, Preschool; Disease-Free Survival; Female; Gentamicins; Guidelines as Topic; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Prospective Studies; Survival Rate

2007
Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Singapore medical journal, 2008, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2008
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Pediatric hematology and oncology, 2008, Volume: 25, Issue:4

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2008
Early granulocyte transfusions in high risk febrile neutropenic patients.
    Schweizerische medizinische Wochenschrift. Supplementum, 1983, Volume: 14

    Topics: Agranulocytosis; Amikacin; Blood Transfusion; Carbenicillin; Clinical Trials as Topic; Gram-Negative Bacteria; Granulocytes; Humans; Neutropenia; Risk; Sepsis

1983
Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:10

    Topics: Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Cefazolin; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Kanamycin; Kidney Diseases; Neoplasms; Neutropenia

1983
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Pseudomonas Infections; Sepsis; Staphylococcal Infections

1984
Combination of amikacin and either ampicillin or cephalotin as initial treatment of febrile neutropenic patients.
    Acta medica Scandinavica, 1982, Volume: 212, Issue:6

    Topics: Adult; Aged; Agranulocytosis; Amikacin; Ampicillin; Bacterial Infections; Cephalothin; Clinical Trials as Topic; Drug Combinations; Female; Fever; Hematologic Diseases; Humans; Kanamycin; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation

1982
Aminoglycosides in the treatment of bacteraemic infections in the immuno-comprised host.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl A

    Topics: Agranulocytosis; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Therapy, Combination; Gentamicins; Humans; Netilmicin; Neutropenia; Sepsis

1981
Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
    American journal of clinical oncology, 1995, Volume: 18, Issue:5

    Topics: Administration, Oral; Adult; Amikacin; Carbenicillin; Ceftazidime; Ciprofloxacin; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillin V; Prospective Studies

1995
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:9

    Topics: Adolescent; Adult; Aged; Amikacin; Amphotericin B; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin

1994
[Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles].
    Presse medicale (Paris, France : 1983), 1995, Feb-25, Volume: 24, Issue:8

    Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam

1995
Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1993, Volume: 76, Issue:6

    Topics: Adolescent; Adult; Aged; Amikacin; Ceftriaxone; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neutropenia; Sepsis

1993
Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:4

    Topics: Adult; Amikacin; Antifungal Agents; Bacterial Infections; Cause of Death; Ceftazidime; Drug Combinations; Female; Humans; Length of Stay; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Neutropenia; Pneumonia; Prognosis; Prospective Studies; Remission Induction; Time Factors; Treatment Outcome

1994
A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients.
    American journal of clinical oncology, 1994, Volume: 17, Issue:5

    Topics: Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Logistic Models; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome

1994
Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
    The European journal of medicine, 1993, Volume: 2, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Vancomycin

1993
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Bacteria; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Teicoplanin

1993
[Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Revista medica de Chile, 1995, Volume: 123, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chi-Square Distribution; Cilastatin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Protease Inhibitors; Thienamycins

1995
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Superinfection

1995
Population pharmacokinetic study of teicoplanin in severely neutropenic patients.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5

    Topics: Adult; Aged; Amikacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neutropenia; Piperacillin; Staphylococcal Infections; Teicoplanin

1996
Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
    Scandinavian journal of infectious diseases, 1996, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Blood; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Neutropenia; Trimethoprim, Sulfamethoxazole Drug Combination

1996
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Neutropenia; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections

1997
Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Chil
    The Pediatric infectious disease journal, 1997, Volume: 16, Issue:4

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia

1997
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
    Annals of hematology, 1998, Volume: 76, Issue:2

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins

1998
Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Enzyme-Linked Immunosorbent Assay; Female; Fever; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Neutropenia; Population

1998
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

1998
Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Anti-Bacterial Agents; Ceftazidime; Chi-Square Distribution; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prognosis; Prospective Studies; Tazobactam; Treatment Failure; Treatment Outcome

1998
Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients.
    Leukemia, 1998, Volume: 12, Issue:10

    Topics: Adult; Amikacin; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fever; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Teicoplanin; Vancomycin

1998
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Cancer, 1999, Jan-01, Volume: 85, Issue:1

    Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Treatment Outcome

1999
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Haematologica, 1999, Volume: 84, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin

1999
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
    The Korean journal of internal medicine, 1999, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam

1999
An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.
    Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Child; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin

1999
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of Turkey.
    International journal of antimicrobial agents, 1999, Volume: 13, Issue:1

    Topics: Adult; Amikacin; Antibiotic Prophylaxis; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Meropenem; Middle Aged; Neutropenia; Prospective Studies; Thienamycins; Treatment Outcome

1999
Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
    Cancer, 2000, Jun-15, Volume: 88, Issue:12

    Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors

2000
Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
    Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome

2000
Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer.
    Journal of paediatrics and child health, 2001, Volume: 37, Issue:1

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Multivariate Analysis; Neoplasms; Neutropenia; Prospective Studies; Statistics, Nonparametric

2001
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Cancer, 2001, Apr-15, Volume: 91, Issue:8

    Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome

2001
Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Amikacin; Cefepime; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Meropenem; Neoplasms; Netilmicin; Neutropenia; Prospective Studies; Thienamycins; Turkey

2001
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Oct-15, Volume: 33, Issue:8

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome

2001
Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies.
    International journal of antimicrobial agents, 2001, Volume: 18, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Fever; Gentamicins; Humans; Male; Neoplasms; Neutropenia; Random Allocation

2001
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.
    Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:11

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Leukemia; Lymphoma, Non-Hodgkin; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome

2001
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin

2002
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2002
A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies.
    Medicine, 1979, Volume: 58, Issue:2

    Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbenicillin; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Parenteral; Kanamycin; Kidney; Male; Middle Aged; Neoplasms; Neutropenia; Uremia

1979
Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients.
    Lancet (London, England), 1992, May-02, Volume: 339, Issue:8801

    Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cloxacillin; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Neutropenia; Ofloxacin; Piperacillin; Prospective Studies

1992
Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 15, Issue:2

    Topics: 4-Quinolones; Amikacin; Anti-Infective Agents; Bacteremia; Drug Therapy, Combination; Female; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Male; Neutropenia; Piperacillin; Prospective Studies; Teicoplanin

1992
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin

1992
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
    Pathologie-biologie, 1992, Volume: 40, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Vancomycin

1992
Ototoxicity associated with a once daily dose amikacin regimen in febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:4

    Topics: Amikacin; Drug Administration Schedule; Fever; Hearing Loss, Sensorineural; Humans; Neutropenia; Pilot Projects

1992
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination

1992
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
    Archives of internal medicine, 1992, Volume: 152, Issue:2

    Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prognosis; Superinfection

1992
The efficacy of mezlocillin-amikacin combination in febrile neutropenic children with oncologic disease.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:4

    Topics: Adolescent; Amikacin; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Haemophilus Infections; Humans; Infant; Male; Mezlocillin; Neisseriaceae Infections; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections

1991
Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.
    Chemotherapy, 1991, Volume: 37, Issue:5

    Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia

1991
Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
    British journal of haematology, 1990, Volume: 76 Suppl 2

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Sepsis; Teicoplanin

1990
Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia.
    European journal of pediatrics, 1989, Volume: 148, Issue:5

    Topics: Agranulocytosis; Amikacin; Antineoplastic Agents; Cefotaxime; Child; Drug Therapy, Combination; Fever; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Infection Control; Leukemia, Myeloid, Acute; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1989
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
    The Pediatric infectious disease journal, 1989, Volume: 8, Issue:5

    Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin

1989
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
    The American journal of medicine, 1989, Nov-30, Volume: 87, Issue:5A

    Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Random Allocation

1989
A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.
    Australian and New Zealand journal of medicine, 1989, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Floxacillin; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Randomized Controlled Trials as Topic; Remission Induction; Therapeutic Equivalency

1989
Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:6

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neutropenia

1989
Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies.
    Acta clinica Belgica, 1989, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation

1989
[Treatment of infectious outbreaks in neutropenic patients with a piperacillin and amikacin combination].
    Presse medicale (Paris, France : 1983), 1986, Dec-20, Volume: 15, Issue:46

    Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neutropenia; Pilot Projects; Piperacillin

1986
[Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Presse medicale (Paris, France : 1983), 1988, Oct-26, Volume: 17, Issue:37

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillins; Prospective Studies; Ticarcillin; Vancomycin

1988
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
    Presse medicale (Paris, France : 1983), 1988, Oct-26, Volume: 17, Issue:37

    Topics: Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Neutropenia; Random Allocation; Vancomycin

1988
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
    The New England journal of medicine, 1988, Oct-20, Volume: 319, Issue:16

    Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillins; Random Allocation; Ticarcillin; Vancomycin

1988
Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Random Allocation

1988
Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies

1988
Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Scandinavian journal of infectious diseases. Supplementum, 1987, Volume: 52

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillin Resistance; Piperacillin; Prospective Studies; Random Allocation; Thienamycins

1987
European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Adult; Agranulocytosis; Amikacin; Bacterial Infections; beta-Lactamase Inhibitors; Child; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Netilmicin; Neutropenia; Penicillins; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin

1987
Review of amikacin usage in the EORTC trials.
    The American journal of medicine, 1985, Jul-15, Volume: 79, Issue:1A

    Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Gentamicins; Humans; International Cooperation; Kanamycin; Kidney Diseases; Lactams; Neoplasms; Neutropenia

1985

Other Studies

74 other study(ies) available for amikacin and Neutropenia

ArticleYear
    Antimicrobial agents and chemotherapy, 2022, 12-20, Volume: 66, Issue:12

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Neutropenia; Nontuberculous Mycobacteria

2022
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    BMC infectious diseases, 2017, 07-17, Volume: 17, Issue:1

    Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins

2017
Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections.
    The Journal of antimicrobial chemotherapy, 2017, Nov-01, Volume: 72, Issue:11

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Chlorocebus aethiops; Disease Models, Animal; Drug Discovery; Kinetics; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Onium Compounds; Small Molecule Libraries; Thienamycins; Vero Cells

2017
In vivo efficacy of apramycin in murine infection models.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Female; Interferon-gamma; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nebramycin; Neutropenia; Staphylococcal Infections; Tuberculosis, Pulmonary

2014
Pharmacodynamics of nine generic products of amikacin compared with the innovator in the neutropenic mouse thigh infection model.
    BMC research notes, 2015, Oct-07, Volume: 8

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Escherichia coli Infections; Mice; Neutropenia

2015
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
    American journal of respiratory and critical care medicine, 2009, Nov-01, Volume: 180, Issue:9

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Thrombocytopenia; Tomography, X-Ray Computed; Treatment Outcome

2009
Cefepime and mortality.
    The Lancet. Infectious diseases, 2009, Volume: 9, Issue:10

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Neutropenia

2009
[Cefepime versus piperacillin/tazobactam with or without amikacin in the treatment of febrile hematological and oncological neutropenic patients in an internal medicine ward].
    Harefuah, 2010, Volume: 149, Issue:12

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome

2010
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:7

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Kidney Diseases; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Survival Analysis; Treatment Outcome

2012
Therapeutic drug monitoring of aminoglycosides in acute myeloid leukaemia patients.
    Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:5

    Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Gentamicins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Practice Guidelines as Topic; Treatment Outcome; Young Adult

2012
Facial ecthyma gangrenosum in 2 preterm neonates.
    Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:7

    Topics: Amikacin; Facial Dermatoses; Fatal Outcome; Female; Gangrene; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Meropenem; Necrosis; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Skin Diseases, Bacterial; Skin Ulcer; Thienamycins

2012
[Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia].
    Harefuah, 2012, Volume: 151, Issue:10

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Candida; Child; Child, Hospitalized; Child, Preschool; Clinical Protocols; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infant; Israel; Male; Microbial Sensitivity Tests; Neutropenia; Piperacillin; Prevalence; Treatment Outcome

2012
Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy.
    British journal of haematology, 2003, Volume: 120, Issue:2

    Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftazidime; Cephalosporins; Chi-Square Distribution; Hematologic Neoplasms; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome

2003
[Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Infant; Neoplasms; Neutropenia; Patient Selection; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome

2003
Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-15, Volume: 39 Suppl 1

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Neutropenia; Opportunistic Infections; Risk Assessment; Sepsis

2004
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
    JPMA. The Journal of the Pakistan Medical Association, 2004, Volume: 54, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin

2004
[Management of febrile neutropenic patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:1

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Fever; Glycopeptides; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunoglobulin G; Infections; Neutropenia

2006
Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 8

    Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bacteremia; Base Sequence; Catheterization, Central Venous; Cytarabine; Humans; Leukemia, Myeloid; Male; Methylobacteriaceae; Molecular Sequence Data; Neutropenia; Penicillanic Acid; Phylogeny; Piperacillin; Piperacillin, Tazobactam Drug Combination; RNA, Bacterial; RNA, Ribosomal, 16S; Vidarabine

2006
Are we finally ready for outpatient management of febrile neutropenia?
    Pediatric blood & cancer, 2007, Volume: 49, Issue:6

    Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Monitoring, Physiologic; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Safety Management; Sepsis; Time Factors

2007
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:5

    Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Cefoxitin; Ceftizoxime; Disease Models, Animal; Drug Combinations; Female; Hydrogen-Ion Concentration; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillins; Protein Binding; Pseudomonas Infections; Rabbits

1984
Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.
    Archives of internal medicine, 1984, Volume: 144, Issue:10

    Topics: Adult; Amikacin; Cefoxitin; Drug Resistance, Microbial; Granulocytes; Humans; Kanamycin; Lymphoma; Male; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Skin Diseases, Infectious

1984
Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
    Medicina, 1981, Volume: 41 Suppl

    Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cephalothin; Cephapirin; Child; Child, Preschool; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Random Allocation; Sepsis; Tobramycin

1981
Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
    Pharmatherapeutica, 1982, Volume: 3, Issue:2

    Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Female; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Rats; Rats, Inbred Strains; Sepsis; Sisomicin; Tobramycin

1982
Treatment and prevention of bacterial infections during cytostatic chemotherapy.
    Acta clinica Belgica, 1981, Volume: 36, Issue:3

    Topics: Agranulocytosis; Amikacin; Bacterial Infections; Blood Transfusion; Carbenicillin; Cephalosporins; Drug Synergism; Granulocytes; Humans; Kanamycin; Neutropenia

1981
Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer.
    Medical and pediatric oncology, 1981, Volume: 9, Issue:5

    Topics: Adolescent; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Evaluation Studies as Topic; Female; Humans; Infant; Kanamycin; Male; Neoplasms; Neutropenia; Penicillins; Ticarcillin

1981
Prediction of amikacin dose requirements in neutropenic patients with haematological disease.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1993, Volume: 83, Issue:11

    Topics: Adolescent; Adult; Amikacin; Bayes Theorem; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia

1993
Ceftazidime and amikacin as empirical treatment of febrile episodes in neutropenic patients.
    The Journal of infection, 1994, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Ceftazidime; Child; Child, Preschool; Fever; Humans; Leukemia; Middle Aged; Neutropenia; Remission Induction

1994
Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication.
    Neoplasma, 1993, Volume: 40, Issue:2

    Topics: Amikacin; Antineoplastic Agents; Bacterial Infections; Candidiasis; Catheterization, Central Venous; Catheterization, Peripheral; Ceftazidime; Ceftriaxone; Drug Therapy, Combination; Hearing; Humans; Kidney; Leukemia; Lymphoma; Neutropenia; Retrospective Studies

1993
Salicylate potentiates amikacin therapy in rodent models of Klebsiella pneumoniae infection.
    The Journal of infectious diseases, 1993, Volume: 168, Issue:3

    Topics: Amikacin; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Mice; Neutropenia; Pneumonia; Rats; Rats, Sprague-Dawley; Sodium Salicylate; Survival Analysis

1993
Disseminating infection with Scytalidium dimidiatum in a granulocytopenic child.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:2

    Topics: Adolescent; Amikacin; Amphotericin B; Ceftazidime; Drug Therapy, Combination; Humans; Immunocompromised Host; Lymphoma, B-Cell; Male; Mitosporic Fungi; Morocco; Mycoses; Netherlands; Neutropenia; Vancomycin

1993
Hypermagnesiuria and hypercalciuria in childhood leukemia: an effect of amikacin therapy.
    Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:1

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Calcium; Child; Child, Preschool; Female; Humans; Kidney Tubules, Proximal; Magnesium; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies

1996
[Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in onco-hematology].
    Pathologie-biologie, 1996, Volume: 44, Issue:4

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Female; France; Hospital Units; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies

1996
[Clinical, pharmacokinetic and therapeutic study of amikacin with single daily dose and in combination in neutropenic children with fever].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3, Issue:9

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neutropenia; Penicillins; Piperacillin; Vancomycin

1996
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF.
    Hematology and cell therapy, 1997, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Adult; Amikacin; Colonic Neoplasms; DNA, Viral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Liver Neoplasms; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human; Pefloxacin; Penicillanic Acid; Piperacillin; Recombinant Proteins; Tazobactam

1997
Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
    American journal of veterinary research, 1998, Volume: 59, Issue:6

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Escherichia coli Infections; Female; Guinea Pigs; Half-Life; Leukocyte Count; Male; Metabolic Clearance Rate; Neutropenia; Neutrophils; Reference Values

1998
Empirical antimicrobial therapy in pediatric patients with neutropenia and fever. Risk factors for treatment failure.
    Archives of medical research, 1998,Winter, Volume: 29, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Child; Drug Therapy, Combination; Fever; Humans; Neutropenia; Risk Factors; Treatment Failure

1998
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
    International journal of antimicrobial agents, 1998, Volume: 10, Issue:4

    Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas

1998
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy.
    Leukemia, 1999, Volume: 13, Issue:4

    Topics: Adult; Aged; Ambulatory Care; Amikacin; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftriaxone; Cerebral Hemorrhage; Cross Infection; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fever; Hospitalization; Humans; Idarubicin; Incidence; Length of Stay; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neutropenia; Remission Induction; Tretinoin

1999
Population pharmacokinetics of amikacin in patients with haematological malignancies.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:2

    Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Models, Biological; Neutropenia; Opportunistic Infections; Reproducibility of Results; Retrospective Studies

1999
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
    Haematologica, 1999, Volume: 84, Issue:9

    Topics: Adult; Ambulatory Care; Amikacin; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftriaxone; Cerebral Hemorrhage; Clinical Trials as Topic; Drug Therapy, Combination; Emergency Service, Hospital; Fever; Hospitalization; Humans; Immunocompromised Host; Italy; Leukemia, Myeloid; Leukocyte Count; Middle Aged; Mycoses; Neutropenia; Staphylococcal Infections

1999
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.
    Medical and pediatric oncology, 2000, Volume: 34, Issue:4

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome

2000
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:2

    Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin

2000
Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
    Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Female; Fluconazole; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Penicillins; Streptococcal Infections; Streptococcus; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination

2000
[Clinical analysis of neutropenic fever associated with hematological disorders].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2001, Volume: 75, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents, Urinary; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Fever; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Serum Albumin; Sulbactam

2001
Aeromonas sobria sepsis in a neutropenic patient.
    Haematologica, 2001, Volume: 86, Issue:4

    Topics: Acute Disease; Aeromonas; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid; Neutropenia; Sepsis

2001
Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
    Infection control and hospital epidemiology, 2001, Volume: 22, Issue:10

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefepime; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Female; Fever; Hospitals, Teaching; Humans; Male; Middle Aged; Neutropenia; Oxacillin; Practice Guidelines as Topic; Teicoplanin; Treatment Outcome; Vancomycin

2001
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
    Haematologica, 2002, Volume: 87, Issue:1

    Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin

2002
Failure of G-CSF therapy in neutropenia associated with Sjögren's syndrome.
    Rheumatology (Oxford, England), 2002, Volume: 41, Issue:4

    Topics: Amikacin; Anemia; Anti-Bacterial Agents; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Immunocompromised Host; Meropenem; Middle Aged; Neutropenia; Opportunistic Infections; Prednisone; Recombinant Proteins; Sjogren's Syndrome; Thienamycins; Thrombocytopenia; Treatment Failure

2002
[Amikacin in the treatment of febrile complications occurring during the neutropenic phase of acute hemopathies].
    La Nouvelle presse medicale, 1979, Oct-31, Volume: 8, Issue:42

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Female; Fever; Humans; Kanamycin; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia

1979
Antimicrobial therapy of septicemia due to Klebsiella pneumoniae in neutropenic rats.
    The Journal of infectious diseases, 1979, Volume: 139, Issue:4

    Topics: Agranulocytosis; Amikacin; Animals; Cefazolin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neutropenia; Rats; Sepsis

1979
[Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
    La Nouvelle presse medicale, 1979, Oct-31, Volume: 8, Issue:42

    Topics: Agranulocytosis; Amikacin; Colistin; Drug Therapy, Combination; Fever; Humans; Kanamycin; Neutropenia; Sulfamethoxazole; Trimethoprim

1979
The pharmacokinetics of amikacin in children.
    The Journal of pediatrics, 1977, Volume: 91, Issue:2

    Topics: Adolescent; Amikacin; Anemia, Aplastic; Appendicitis; Child; Child, Preschool; Cystic Fibrosis; Female; Half-Life; Humans; Kanamycin; Kidney; Leukemia; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Pelvic Inflammatory Disease

1977
Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia.
    The Journal of infection, 1992, Volume: 25, Issue:1

    Topics: Adult; Amikacin; Ceftazidime; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Mycoses; Neoplasms; Neutropenia; Saudi Arabia; Sepsis; Treatment Outcome

1992
Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies.
    Oncology, 1992, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Day Care, Medical; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Pilot Projects

1992
[Study of the effect of combination therapy of human granulocyte-colony stimulating factor (G-CSF) and amikacin on experimental pyelonephritis induced by Pseudomonas aeruginosa in neutropenic mice].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1990, Volume: 64, Issue:8

    Topics: Amikacin; Animals; Combined Modality Therapy; Female; Granulocyte Colony-Stimulating Factor; Mice; Mice, Inbred Strains; Neutropenia; Pseudomonas Infections; Pyelonephritis

1990
Ceftriaxone plus amikacin in neutropenic patients: a report on 100 cases.
    Chemotherapy, 1991, Volume: 37, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftriaxone; Child; Drug Therapy, Combination; Humans; Leukemia; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia

1991
Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5

    Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Agents; Body Weight; Female; Half-Life; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Regression Analysis

1991
Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
    British journal of haematology, 1990, Volume: 76 Suppl 2

    Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Bone Marrow Transplantation; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Glycopeptides; Gram-Positive Bacteria; Humans; Leukemia; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Sepsis; Teicoplanin

1990
Circadian variation in serum amikacin levels.
    Journal of clinical pharmacology, 1990, Volume: 30, Issue:9

    Topics: Amikacin; Circadian Rhythm; Female; Humans; Male; Middle Aged; Neutropenia; Time Factors

1990
[Combined chemotherapy of experimental infection in neutropenia].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1989, Volume: 34, Issue:5

    Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Immune Tolerance; Klebsiella Infections; Mice; Neutropenia; Opportunistic Infections; Pseudomonas Infections

1989
Combination antibiotic treatment of chemotherapy-induced neutropenia in non-leukemic patients.
    Tumori, 1989, Oct-31, Volume: 75, Issue:5

    Topics: Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Clindamycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies

1989
[Infections in neutropenic children with neoplasms. Case series contribution].
    Minerva pediatrica, 1988, Volume: 40, Issue:6

    Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leukemia; Lymphoma; Male; Neoplasms; Neutropenia

1988
Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.
    Diagnostic microbiology and infectious disease, 1987, Volume: 6, Issue:1

    Topics: Amikacin; Animals; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia marcescens

1987
Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:6

    Topics: Agranulocytosis; Amikacin; Animals; Ceftazidime; Drug Therapy, Combination; Female; Kinetics; Microbial Sensitivity Tests; Neutropenia; Penicillins; Peritoneal Cavity; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Ticarcillin

1987
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
    Diagnostic microbiology and infectious disease, 1987, Volume: 7, Issue:2

    Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Kinetics; Neutropenia; Penicillin G; Rabbits; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae

1987
Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
    Australian and New Zealand journal of medicine, 1988, Volume: 18, Issue:6

    Topics: Agranulocytosis; Amikacin; Australia; Cefotaxime; Drug Therapy, Combination; Gentamicins; Hospitals, Teaching; Humans; Neutropenia; Piperacillin; Sepsis; Ticarcillin

1988
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
    The Journal of infectious diseases, 1986, Volume: 154, Issue:4

    Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins

1986
Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    The American journal of medicine, 1986, May-30, Volume: 80, Issue:5C

    Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Drug Therapy, Combination; Female; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Penicillins; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Ticarcillin

1986
In vitro models for the study of combination antibiotic therapy in neutropenic patients.
    The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B

    Topics: Agranulocytosis; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Carbenicillin; Cefazolin; Cephalothin; Drug Therapy, Combination; Gentamicins; Humans; Models, Biological; Neutropenia; Pseudomonas Infections; Risk

1986
Combination antibiotic therapy in pediatrics.
    The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Infant; Infant, Newborn; Kanamycin; Lactams; Neutropenia; Peritoneal Dialysis, Continuous Ambulatory; Pseudomonas Infections; Risk

1986
Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 15 Suppl A

    Topics: Agranulocytosis; Amikacin; Animals; Cefotaxime; Ceftizoxime; Drug Combinations; Enterobacteriaceae; Female; Hydrogen-Ion Concentration; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Neutropenia; Rabbits

1985
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
    Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:6

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Neutropenia; Penicillin Resistance; Peritonitis; Piperacillin; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis

1985
Forecast of antibiotic susceptibility of translocating strains of enterobacteria and pseudomonas in leukemic neutropenic patients.
    Progress in clinical and biological research, 1985, Volume: 181

    Topics: Agranulocytosis; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Enterobacteriaceae; Feces; Gentamicins; Humans; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pseudomonas

1985
Treatment of pediatric infections with amikacin as first-line aminoglycoside.
    The American journal of medicine, 1985, Jul-15, Volume: 79, Issue:1A

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Chicago; Child; Drug Resistance, Microbial; Drug Synergism; Drug Utilization; Gram-Negative Bacteria; Hospitals, Pediatric; Humans; Infant, Newborn; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Pediatrics; Pseudomonas; Staphylococcus

1985